Drugs / GW493838
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00376454 | Nov 2002 → Jun 2003 | neuropathy, painful | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW493838 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00376454 ↗ |
| Known as | GW-493838 X | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314395 ↗ |
| Action | Activate | “The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain” NCT00376454 ↗1“Adenosine A1 receptor agonist” CHEMBL5314395 ↗ |
| Modality | Small molecule | — CHEMBL5314395 ↗ |
| Target | ADORA1 | “Adenosine A1 receptor agonist” CHEMBL5314395 ↗ |